$15.40
$-0.23 (-1.47%)
End-of-day quote: 05/14/2024
NasdaqCM:NEO
NeoGenomics Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $594.80 | $591.94 | 0.00% | 1 | $227.04B |
| NOVN | Novartis | SWX | Hold | CHF93.49 | CHF105.00 | 0.00% | 9 | CHF190.76B |
| ROG | Roche Holding | SWX | Hold | CHF224.60 | CHF307.83 | 0.00% | 9 | CHF181.26B |
| ABT | Abbott Laboratories | NYSE | Outperform | $104.01 | $118.92 | 0.00% | 7 | $180.94B |
| ILMN | Illumina | NasdaqGS | Outperform | $115.58 | $159.28 | 0.00% | 9 | $18.41B |
| LH | Laboratory Corp of America Hol... | NYSE | Outperform | $211.20 | $241.28 | 0.00% | 9 | $17.80B |
| HOLX | Hologic | NasdaqGS | Outperform | $75.65 | $81.06 | 0.00% | 3 | $17.65B |
| DGX | Quest Diagnostics | NYSE | Outperform | $139.16 | $141.17 | 0.00% | 8 | $15.38B |
| NTRA | Natera | NasdaqGS | Buy | $105.52 | $74.41 | 0.00% | 8 | $11.68B |
| 6869 | Sysmex | TSE | Outperform | ¥7.99k | ¥8.90k | 0.00% | 0 | ¥1.74T |
| EXAS | Exact Sciences | NasdaqCM | Buy | $54.00 | $90.32 | 0.00% | 7 | $9.96B |
| QGEN | QIAGEN N.V. | NYSE | Outperform | $45.39 | $0.00 | 0.00% | 3 | $9.67B |
| SHL | Sonic Healthcare | ASX | Hold | $27.62 | $34.12 | 0.00% | 0 | $12.78B |
| GH | Guardant Health | NasdaqGS | Buy | $24.73 | $43.00 | 0.00% | 2 | $2.37B |
| MYGN | Myriad Genetics | NasdaqGS | Outperform | $25.36 | $22.08 | 0.00% | 8 | $1.79B |
| VCYT | Veracyte | NasdaqGM | Outperform | $23.02 | $32.17 | 0.00% | 4 | $1.61B |
| OPK | OPKO Health | NasdaqGS | Outperform | $1.01 | $6.70 | 0.00% | 0 | $1.18B |
| FLGT | Fulgent Genetics | NasdaqGM | Hold | $22.32 | $31.50 | 0.00% | 2 | $642.86M |
| CDNA | CareDx, Inc | NasdaqGM | Outperform | $15.24 | $11.80 | 0.00% | 1 | $575.21M |
| ADPT | Adaptive Biotechnologies | NasdaqGS | Outperform | $3.96 | $8.67 | 0.00% | 2 | $515.79M |
| ATOS | Atossa Genetics Inc | NASDAQ | Buy | $1.54 | $4.83 | 0.00% | 0 | $187.38M |
| A038290 | Macrogen | KOSDAQ | Buy | ₩22.10k | ₩30.00k | 0.00% | 0 | ₩220.54B |
| CRDF | Cardiff Oncology | NasdaqCM | Buy | $3.58 | $8.37 | 0.00% | 1 | $154.70M |
| PSNL | Personalis | NasdaqGM | Outperform | $1.52 | $4.45 | 0.00% | 3 | $80.14M |
| AGL | ANGLE | AIM | Buy | £0.21 | £0.97 | 0.00% | 0 | £46.23M |
| PEB | Pacific Edge | NZSE | Hold | $0.09 | $0.14 | 0.00% | 2 | $75.45M |
| 8YY | Biolidics | Catalist | - | $0.01 | $0.00 | 0.00% | 0 | $53.09M |
| AXDX | Accelerate Diagnostics | NasdaqCM | Buy | $0.91 | $5.00 | 0.00% | 1 | $19.07M |
| PRPO | Precipio | NasdaqCM | - | $6.49 | $19.00 | 0.00% | 1 | $8.87M |
| NSTG | NanoString Technologies | NasdaqGM | - | $0.12 | $5.02 | 0.00% | 4 | $5.17M |
| NVTA | Invitae | NYSE | - | $0.00 | $0.71 | 0.00% | 8 | $3.18M |
| BIOC.Q | Biocept | OTCPK | Hold | $0.00 | $8.00 | 0.00% | 0 | $0.13M |
| ROSG.Q | Rosetta Genomics | OTCPK | - | $0.00 | $0.00 | 0.00% | 0 | $0.00M |
| HTGM.Q | HTG Molecular Diagnostics | OTCPK | - | $0.00 | $6.00 | 0.00% | 1 | $0.00M |
